Skip to main content
. 2023 May 22;85(7):3563–3573. doi: 10.1097/MS9.0000000000000844

Figure 8.

Figure 8

Forest plots evaluating the safety outcomes of pimecrolimus versus vehicle for gastrointestinal symptoms.